Persistent pathways after lung radiofrequency ablation as a risk factor of drain placement.

about

Persistent pathways after lung radiofrequency ablation as a risk factor of drain placement.

Item

http://www.wikidata.org/entity/Q53803862

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Persistent pathways after lung ...... isk factor of drain placement.

@en

Persistent pathways after lung ...... isk factor of drain placement.

@nl

type

Item

label

Persistent pathways after lung ...... isk factor of drain placement.

@en

Persistent pathways after lung ...... isk factor of drain placement.

@nl

prefLabel

Persistent pathways after lung ...... isk factor of drain placement.

@en

Persistent pathways after lung ...... isk factor of drain placement.

@nl

P1476

Persistent pathways after lung ...... risk factor of drain placement

@en

P2093

Jean-Michel Bartoli

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Gaubert

http://www.w3.org/2001/XMLSchema#string

Kathia Chaumoitre

http://www.w3.org/2001/XMLSchema#string

Marie Lignieres

http://www.w3.org/2001/XMLSchema#string

Nicolas Roux

http://www.w3.org/2001/XMLSchema#string

Vincent Vidal

http://www.w3.org/2001/XMLSchema#string

P2860

Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases.

Lung cancer and radiofrequency ablation.

Risk factors for pneumothorax complicating radiofrequency ablation for lung malignancy: a systematic review and meta-analysis.

Treating bronchopleural fistulae percutaneously with N-butyl cyanoacrylate glue.

Quantification of pneumothorax size on chest radiographs using interpleural distances: regression analysis based on volume measurements from helical CT.

Bronchopleural fistula treatment with use of a bronchial stent-graft occluder.

Outcomes of an algorithmic approach to management of pneumothorax complicating thermal ablation of pulmonary neoplasms.

Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: results of eight years' experience in 87 patients from two centers.

P304

659-663

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/02656736.2017.1288931

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roch Giorgi

Jean Izaaryene

P577

2017-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28540780

http://www.w3.org/2001/XMLSchema#string

P921

risk factor